References
Hoshino T, Rodriguez LA, Cho KG, Lee KS, Wilson CB, Edwards MSB, Levin VA, Davis RL: Prognostic implications of the proliferative potential of lowgrade astrocytomas. J Neurosurg 69: 839–842, 1988
Ito S, Chandler KL, Prados MD, Lamborn K, Wynne J, Malec MK, Wilson CB, Davis RL, Hoshino T: Proliferative potential and prognostic evaluation of low-grade astrocytomas. J of Neuro-Oncology 19: 1–9, 1994
Onda K, Davis RL, Wilson CB, Hoshino T: Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme. Acta Neuropathol (Berlin) 87: 586–593, 1994
Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T: Correlation between bromodeoxyuridine labeling index and MIB1 and KI-67 proliferating cell indices in cerebral gliomas: MIB 1 immunohistochemistry as a proliferation marker. Cancer 1994
Onda K, Davis RL, Edwards MSB: Regional difference of growth potential in medulloblastomas: double immunohistochemical staining using anti-bromodeoxyuridine and MIB 1 monoclonal antibodies. J Neurooncology, submitted
Wacker M, Hoshino T, Ahn DK, Davis RL, Prados MD: The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas. J of Neuro-Oncology 19: 113–122, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davis, R.L., Onda, K., Shubuya, M. et al. Proliferation markers in gliomas: A comparison of BUDR, KI-67, and MIB-1. J Neuro-Oncol 24, 9–12 (1995). https://doi.org/10.1007/BF01052651
Issue Date:
DOI: https://doi.org/10.1007/BF01052651